Eli Lilly's Insulin Price Cap Deal Collapses After Cert. Denial

By Hailey Konnath · April 16, 2024, 11:08 PM EDT

Eli Lilly & Co. and insulin buyers have called off a proposed nationwide settlement that would've capped insulin prices and been worth up to $500 million over several years, a decision...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

CHAIRES et al v. NOVO NORDISK INC. et al

Case Number

2:17-cv-00699

Court

New Jersey

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

February 02, 2017